This observation may indicate that KLK6 is associated with Tau pathology and has the potential to be a suitable biomarker in tau pathology Alzheimer’s disease-related (Goldhardt et al., 2019). Here, KLK6 is linked to early-onset autosomal dominant Alzheimer disease.